Related Experiment Videos

Further rationale for optimal combined modality treatments

Robert J Griffin¹, Ruud P M Dings¹, Issam Makhoul²

¹Department of Radiation Oncology, Radiation Biology Division, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

|April 19, 2017

Summary

No abstract available in PubMed .

Keywords:

anti-angiogenic agent radiotherapy re-oxygenation sunitinib

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Synthesis of Peptide Analogs From Fish Venom With Potential Antimicrobial and Anticancer Activity.

Chemical biology & drug design·2026

Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy.

International journal of pharmaceutics·2026

Detection of mitochondrial DNA mutations in T cells following 5-FU or cisplatin exposure.

Cell reports. Medicine·2026

Modified tumor uptake and biodistribution of nanoparticles coated with small extracellular vesicle membranes derived from distinct tumor cell lines.

International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·2026

Historical Review of the Role of Indirect Cell Death in High-Dose Per Fraction Radiation Therapy.

Advances in radiation oncology·2026

Lattice radiation therapy for canine sinonasal carcinoma: feasibility study of spatially fractionated radiotherapy using volumetric modulated arc therapy.

BMC veterinary research·2025

See all related articles